MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

EMG-US guided incobotulinum toxinA treatment of a cohort of musicians affected by upper limb focal dystonia

A. Castagna, M. Ramella, G. Giacobbi, P. Cecconi, R. Converti (Milano, Italy)

Meeting: 2017 International Congress

Abstract Number: 1223

Keywords: Dystonia: Treatment

Session Information

Date: Thursday, June 8, 2017

Session Title: Dystonia

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: To demonstrate the efficacy and safety of incobotulinumtoxinA  and the importance of simultaneous US and EMG guide in targeting single finger muscles in musician’s dystonia

Background: Musician’s dystonia is a task specific  movement disorder which  presents as loss of voluntary motor control in extensively trained movements. Botulinum toxin (BoNT) injected in dystonic muscles  is considered an efficacious treatment (1);  US guide has recently been recognize to be  useful in the muscle targeting (2).

Methods: musicians affected by upper limb focal dystonia,  afferent in the last 3 years to the “Sol Diesis clinic” were clinically analyzed  and video recorde by a multispecialist  skilled team during musical performance and  treated with a EMG-US guided incobotulinumtoxinA injections in the dystonic muscles. Patients were asked to estimate their average playing ability before and after each toxin treatment using a VAS Performance Scale.  

Data were statistically analyzed using  Student t test. 

Results: 15 musicians (mean age 43,9± 14,54; 14 males and 1 female), 10 professional player (3 violin, 4 guitar,1 electric guitar, 1 director, 1 accordion) and 5 professional teachers (4 guitar, 1 flute) were treated.  No major side effect were reported  (only one case of overshoot weakness after injection); inter-injection intervals were variable;  in one case  boost injections  were performed.

Significant statistically improvement of the  VAS Performance  Scale after each treatment (22 treatments)  was recorded (p< .05) with a mean value of  VAS 4.74 ±1.6 pre and 6.63±2.16 post.

10 patients received only one treatment .3  musicians have  3 years follow up with repeated efficacious injections; 8 patients perform regular professional orchestral and soloist activity. Median efficacious dosage on  single finger flexors muscle, injected in 12 pts (Flexor digitorum superficialis/profundus) was 11 ± 7.4 U (dilution 100 U in 1 ml). 7 patients associated motor learning techniques with BoNT injections.

Conclusions: IncobotulinumtoxinA can be considered  an efficacious  treatment  in  musician’s upper limb  dystonia in particular involving finger flexors muscles, also at low dosage, with limited  side effects.  EMG-US guide is very useful in the diagnostic targeting process and to determine an efficacious dosage.

References: 1) Schuele  S et al. Botulinum toxin injections in the treatment of musician’s dystonia.Neurology 2005 .

2) Walter U1, Dressler D Ultrasound-guided botulinum toxin injections in neurology: technique, indications and future perspectives. Expert Rev Neurother. 2014 Aug;14(8):923-36. doi: 10.1586/14737175.2014.936387. Epub 2014 Jul 21.

To cite this abstract in AMA style:

A. Castagna, M. Ramella, G. Giacobbi, P. Cecconi, R. Converti. EMG-US guided incobotulinum toxinA treatment of a cohort of musicians affected by upper limb focal dystonia [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/emg-us-guided-incobotulinum-toxina-treatment-of-a-cohort-of-musicians-affected-by-upper-limb-focal-dystonia/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/emg-us-guided-incobotulinum-toxina-treatment-of-a-cohort-of-musicians-affected-by-upper-limb-focal-dystonia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley